one
largest
emerg
depart
clinic
trial
subject
perhap
one
includ
children
consequ
lack
rigour
undertak
literatur
search
result
omiss
relev
random
control
trial
introduc
bia
potenti
lead
incorrect
conclus
drawn
furthermor
author
fail
undertak
metaanalysi
incomplet
pool
data
order
determin
overal
effect
buffer
clinic
andor
statist
heterogen
studi
review
may
preclud
analysi
mention
within
paper
therefor
conclus
systemat
review
rather
select
narr
review
literatur
larg
potenti
bia
author
conclus
must
view
great
caution
equal
find
surpris
author
use
nhmrc
guidelin
rate
qualiti
evid
rather
recent
edit
reader
formul
opinion
use
otherwis
buffer
lignocain
howev
review
assist
make
decis
davi
rj
buffer
pain
local
anaesthet
systemat
review
emerg
med
fatovich
dm
jacob
ig
random
control
trial
buffer
lidocain
local
anesthet
infiltr
children
adult
simpl
lacer
j
emerg
med
fatovich
dm
jacob
ig
random
control
trial
oral
midazolam
buffer
lidocain
sutur
lacer
children
slic
trial
ann
emerg
med
nhmrc
guid
develop
implement
evalu
clinic
practic
guidelin
magnesium
often
overshadow
electrolyt
particularli
sodium
potassium
physiolog
text
despit
limit
therapeut
agent
magnesium
import
intracellular
cation
magnesium
disord
uncommon
critic
ill
patient
review
magnesium
wallac
time
succinct
discuss
number
potenti
therapeut
use
magnesium
ed
would
like
briefli
add
coupl
recent
publish
paper
lend
support
wallac
conclus
first
result
magnesium
coronari
trial
magic
recent
publish
multicentr
placebocontrol
random
doubleblind
trial
patient
acut
stelev
myocardi
infarct
stemi
found
magnesium
sulphat
g
intraven
bolu
min
follow
g
infus
h
administ
within
hour
onset
symptom
effect
primari
endpoint
day
allcaus
mortal
compar
placebo
day
mortal
magnesium
group
vs
placebo
group
odd
ratio
ci
p
benefit
harm
magnesium
buffer
pain
local
anaesthet
unsystemat
review
read
interest
paper
davi
buffer
pain
local
anaesthet
report
conduct
systemat
review
relev
literatur
paper
systemat
review
search
method
describ
incomplet
requir
systemat
review
notabl
lack
basic
requir
search
multipl
databas
includ
embas
cochran
clinic
trial
regist
addit
key
word
use
insuffici
confid
detect
relev
trial
exampl
differ
spell
anaesthet
anesthet
differ
tens
buffer
buffer
plural
singular
anaesthet
anaesthet
differ
name
lignocain
lidocain
result
vastli
differ
number
appropri
paper
retriev
thorough
search
strategi
employ
author
would
identifi
least
two
random
control
trial
conduct
australia
one
largest
emerg
depart
clinic
trial
subject
perhap
one
includ
children
consequ
lack
rigour
undertak
literatur
search
result
omiss
relev
random
control
trial
introduc
bia
potenti
lead
incorrect
conclus
drawn
furthermor
author
fail
undertak
metaanalysi
incomplet
pool
data
order
determin
overal
effect
buffer
clinic
andor
statist
heterogen
studi
review
may
preclud
analysi
mention
within
paper
therefor
conclus
systemat
review
rather
select
narr
review
literatur
larg
potenti
bia
author
conclus
must
view
great
caution
equal
find
surpris
author
use
nhmrc
guidelin
rate
qualiti
evid
rather
recent
edit
reader
formul
opinion
use
otherwis
buffer
lignocain
howev
review
assist
make
decis
magnesium
often
overshadow
electrolyt
particularli
sodium
potassium
physiolog
text
despit
limit
therapeut
agent
magnesium
import
intracellular
cation
magnesium
disord
uncommon
critic
ill
patient
review
magnesium
wallac
time
succinct
discuss
number
potenti
therapeut
use
magnesium
ed
would
like
briefli
add
coupl
recent
publish
paper
lend
support
wallac
conclus
first
result
magnesium
coronari
trial
magic
recent
publish
multicentr
placebocontrol
random
doubleblind
trial
patient
acut
stelev
myocardi
infarct
stemi
found
magnesium
sulphat
g
intraven
bolu
min
follow
g
infus
h
administ
within
hour
onset
symptom
effect
primari
endpoint
day
allcaus
mortal
compar
placebo
day
mortal
magnesium
group
vs
placebo
group
odd
ratio
ci
p
benefit
harm
magnesium
observ
sever
subgroup
analys
evid
benefit
magnesium
major
secondari
endpoint
treatment
heart
failur
defibril
lifethreaten
ventricular
arrhythmia
investig
point
discuss
paper
mean
patient
studi
past
year
random
trial
magnesium
myocardi
infarct
unfortun
despit
potenti
costeffect
inescap
conclus
appear
intraven
magnesium
sulphat
routin
therapeut
role
manag
stemi
apart
replet
document
hypomagnesaemia
second
multicentr
placebocontrol
random
doubleblind
trial
intraven
magnesium
sulphat
patient
acut
sever
asthma
recent
report
trial
g
magnesium
sulphat
placebo
administ
intraven
min
ed
arriv
primari
endpoint
fev
min
found
higher
magnesium
treat
group
mean
fev
predict
vs
predict
placebo
group
mean
differ
ci
p
effect
magnesium
greater
patient
lower
initi
fev
howev
use
magnesium
improv
overal
hospit
admiss
rate
result
support
conclus
magnesium
sulphat
weak
bronchodil
may
use
adjunct
standard
therapi
patient
acut
sever
asthma
craig
hore
mbb
absolut
lymphocyt
count
taken
first
day
admiss
hospit
may
use
predict
sar
hong
kong
one
worst
area
world
hit
sar
emerg
primari
care
physician
face
dilemma
deal
diseas
novel
easi
miss
case
definit
sar
describ
evolv
new
inform
aris
includ
fever
chest
xray
chang
laboratori
test
coronaviru
definit
differ
hospit
author
depart
health
hong
kong
earli
phase
crisi
singl
definit
singl
test
indic
diseas
investig
patient
admit
consecut
suspect
sar
hospit
tuen
mun
twoweek
period
hospit
situat
west
hong
kong
catchment
popul
million
peopl
annual
censu
ed
patient
suspect
sar
defin
fever
temperatur
day
chest
xray
chang
show
evid
consolid
without
respiratori
symptom
cough
short
breath
least
two
follow
chill
increas
cough
malais
histori
exposur
patient
suspect
sar
admit
data
collect
accid
emerg
record
admiss
hospit
comput
system
upon
discharg
demograph
data
includ
gender
age
physiolog
data
includ
blood
pressur
puls
rate
temperatur
respiratori
rate
oxygen
satur
clinic
data
present
includ
cough
diarrhoea
chill
malais
myalgia
white
cell
count
absolut
lymphocyt
count
collect
day
admiss
whilst
pcr
result
perform
sampl
taken
day
onset
symptom
coronaviru
also
record
patient
divid
two
group
confirm
sar
nonsar
subsequ
inpati
diagnost
criteria
incorpor
use
pcr
assay
coronaviru
saliva
urin
stool
togeth
serolog
chang
fiftyfour
patient
includ
studi
patient
confirm
sar
patient
die
cohort
demograph
data
compar
two
group
mean
age
sd
sd
year
old
nonsar
sar
group
proport
femal
gender
sar
nonsar
group
patient
respiratori
symptom
chest
xray
chang
indic
pneumonia
ten
patient
sar
group
patient
nonsar
group
fever
mean
absolut
lymphocyt
count
l
sd
sar
group
l
sd
nonsar
group
cutoff
absolut
lymphocyt
count
give
sensit
ci
specif
ci
fig
posit
predict
valu
neg
predict
valu
area
receiv
oper
curv
ci
fig
applic
absolut
lymphocyt
count
diagnosi
sar
earli
phase
present
appear
promis
may
consid
futur
guidelin
